Testing effectiveness (Phase 2)UnknownNCT04835584What this trial is testingKRT-232 and TKI Study in Chronic Myeloid LeukemiaWho this might be right forChronic Myeloid Leukemia Kartos Therapeutics, Inc. 109
Early research (Phase 1)Ended earlyNCT00933985What this trial is testingObatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or LeukemiaWho this might be right forAcute Leukemias of Ambiguous LineageAcute Undifferentiated LeukemiaAngioimmunoblastic T-cell Lymphoma+26 more National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Study completedNCT00732316What this trial is testingDonor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematologic Cancer or Myelodysplastic SyndromeWho this might be right forLeukemiaMyelodysplastic Syndromes Asan Medical Center 54
Early research (Phase 1)Study completedNCT00004904What this trial is testingStem Cell Transplantation in Treating Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more Northwestern University
Testing effectiveness (Phase 2)Study completedNCT00066599What this trial is testingVoriconazole in Preventing Fungal Infections in Children With Neutropenia After ChemotherapyWho this might be right forKidney CancerLeukemiaLymphoma+6 more National Cancer Institute (NCI)
Not applicableUnknownNCT06121765What this trial is testingMetabolic Alternation and Clinicohematological Characteristic in Chronic Phase CML in Patient Treated With TKIWho this might be right forCML, Chronic Phase Assiut University 45
Testing effectiveness (Phase 2)Study completedNCT00109707What this trial is testingOral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic MalignanciesWho this might be right forChronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)Hypereosinophilic Syndrome+1 more Novartis Pharmaceuticals 507
Early research (Phase 1)Ended earlyNCT00852709What this trial is testingPhase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute LeukemiasWho this might be right forMyelodysplastic SyndromeAcute Myeloid LeukemiaMyeloproliferative Disorders+7 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Large-scale testing (Phase 3)UnknownNCT02381379What this trial is testingMalaysia Stop Tyrosine Kinase Inhibitor TrialWho this might be right forLeukemia, Chronic Myeloid Ministry of Health, Malaysia 118
Not applicableStudy completedNCT00001623What this trial is testingBone Marrow Transplant Studies for Safe and Effective Treatment of LeukemiaWho this might be right forGraft vs Host DiseaseHematologic NeoplasmLeukemia+2 more National Heart, Lung, and Blood Institute (NHLBI) 41
Testing effectiveness (Phase 2)Ended earlyNCT00593554What this trial is testingPhase 2 Haplotype Mismatched HSCT in Patients With Hematological MalignanciesWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplasia+1 more Sherif S. Farag 9
Testing effectiveness (Phase 2)UnknownNCT02949570What this trial is testingStudy to Assess Efficacy and Safety of Inecalcitol in Imatinib-Treated Residual Chronic Myeloid Leukaemia: INIM StudyWho this might be right forCML, Chronic Phase Hybrigenics Corporation 54
Testing effectiveness (Phase 2)WithdrawnNCT00570999What this trial is testingPalifermin After Haploidentical PBSCTWho this might be right forNon-Hodgkin's Lymphoma or Hodgkin's DiseaseAcute LeukaemiaMyelodysplastic Syndrome+2 more European Society for Blood and Marrow Transplantation
Testing effectiveness (Phase 2)Study completedNCT02888964What this trial is testingPioglityazone and Imatinib for CML PatientsWho this might be right forLeukemia, Myeloid, Chronic-Phase Versailles Hospital 27
Not applicableLooking for participantsNCT06130787What this trial is testingValue of Biological Age, in Addition to Individual Frailty, for Personalising the Management of Cancer Treated with Targeted TherapyWho this might be right forLeukemia,Myeloid, Chronic University Hospital, Clermont-Ferrand 321
Testing effectiveness (Phase 2)UnknownNCT00036712What this trial is testingLight-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow TransplantationWho this might be right forChronic Myeloproliferative DisordersKidney CancerLeukemia+9 more Medical College of Wisconsin 80
Testing effectiveness (Phase 2)Study completedNCT00003406What this trial is testingCombination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Cancer Treatment Centers of America 30
Not applicableApproved For MarketingNCT01592136What this trial is testingExpanded Access Program of PonatinibWho this might be right forChronic Myeloid Leukemia (CML)Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Ariad Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT00579111What this trial is testingReduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)Who this might be right forMyelodysplastic and Myeloproliferative DisordersAcute Myelogenous LeukemiaAcute Lymphoblastic Leukemia+5 more Baylor College of Medicine 4
Not applicableStudy completedNCT01114087What this trial is testingImpact of the Inhibitors of Tyrosine Kinase on the Male FertilityWho this might be right forChronic Myeloid LeukemiaGastrointestinal Stromal Tumors Assistance Publique - Hôpitaux de Paris 2